Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

15.09.14	Amgen Presents Phase 3 Ivabradine Data On Chronic Heart Failure Treatment (RTTNews)
02.09.14	Amgen Submits MAA In Europe For Talimogene Laherparepvec (RTTNews)
02.09.14	Amgen Files MAA To EMA For Investigational Medication Evolocumab (RTTNews)
28.08.14	Amgen Submits BLA For Evolocumab - Quick Facts (RTTNews)
27.08.14	Amgen Gets FDA Priority Review For Heart Drug - Update (RTTNews)
19.08.14	Amgen Says Second Phase 3 Study Of AMG 416 Meets Goals (RTTNews)
14.08.14	Amgen Blood Cancer Drug Fails Primary Endpoint In Late-Stage Study (RTTNews)
13.08.14	Amgen Reports Recall Of Nine Packaged Lots Of Aranesp - Quick Facts (RTTNews)
13.08.14	Amgen Says Phase 3 Focus Trial Fails To Meet Primary Endpoint (RTTNews)
04.08.14	Amgen Blood Cancer Drug Meets Primary Endpoint In Late-Stage Study (RTTNews)
04.08.14	Amgen: Phase 3 Study In Multiple Myeloma Meets Primary Goal (RTTNews)
30.07.14	After-market Movers For July 29 (TWTR, AMGN, ZLTQ, DWA, BWLD) (RTTNews)
29.07.14	Amgen Profit Tops Street, Lifts Outlook; To Cut Up To 2,900 Jobs (RTTNews)
29.07.14	Amgen Q2 Results Top Estimates; To Cut 2,400-2,900 Jobs (RTTNews)
29.07.14	Earnings Watch For July 29 (TWTR, AET, RAI, SIRI, UPS, PNRA, WYNN) (RTTNews)
25.07.14	Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint (RTTNews)
18.07.14	Amgen Reports Positive Phase 3 Results For Thyroid Drug AMG 416 (RTTNews)
01.07.14	Amgen Receives FDA Breakthrough Therapy Status For Blinatumomab In Leukemia (RTTNews)
20.06.14	Bayer: Nexavar Approved In Japan For Treatment Of Thyroid Cancer - Quick Facts (RTTNews)
09.06.14	Amgen Names David Meline CFO - Update (RTTNews)
09.06.14	Amgen Appoints David Meline As EVP, CFO - Quick Facts (RTTNews)
02.06.14	Amgen: Clinical Trials Support Potential Of Talimogene In Metastatic Melanoma (RTTNews)
24.05.14	Amgen's Colon Cancer Drug Vectibix Gets Expanded FDA Approval (RTTNews)
13.05.14	Amgen: Evolocumab In Combination With Statin Therapy Reduces LDL Cholesterol (RTTNews)
09.05.14	Amgen, AstraZeneca Say Ph 3 Study Of Psoriasis Drug Brodalumab Meets Goals (RTTNews)
23.04.14	After-market Movers For April 22 (T, AMGN, YUM, GILD, SWKS, SMCI, ILMN, SKX, CREE, ISRG) (RTTNews)
22.04.14	Amgen Profit Falls 25% (RTTNews)
22.04.14	Amgen Profit Falls Amid Revenue Growth, Misses Estimate - Quick Facts (RTTNews)
22.04.14	Earnings Watch For April 22 (MCD, JNPR, UTX, TRV, AMGN, T, XRX) (RTTNews)
04.04.14	Amgen Updates On Talimogene Laherparepvec Phase 3 Study In Metastatic Melanoma (RTTNews)
30.03.14	Amgen Reports Data From Phase 3 Studies On Evolocumab (RTTNews)
29.03.14	Amgen's New Data Shows Positive Results For Cholesterol Drug Evolocumab (RTTNews)
18.03.14	ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move (RTTNews)
17.03.14	Amgen: Phase 3 TESLA Trial Meets Primary Goal Of LDL Cholesterol Reduction (RTTNews)
14.03.14	Amgen: Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Study (RTTNews)
11.03.14	Bayer And Onyx Say Nexavar Fails To Meet Primary Endpoint In Liver Cancer Trial (RTTNews)
05.02.14	Merck Q4 Profit Down 14%, But Matches View; Sees 2014 Earnings In-line (RTTNews)
05.02.14	Merck, Amgen,Incyte And Pfizer To Collaborate On Anti-Cancer Combination Studies (RTTNews)
05.02.14	Amgen, Merck Collaborate To Evaluate Combination Treatment For Advanced Melanoma (RTTNews)
31.01.14	ARAY On The Rise, AERI Catching Eyes, CORT Growing Big, SLXP Gets FDA Date (RTTNews)
31.01.14	Amgen Says Evolocumab Meets Primary Goals In Late-Stage Study (RTTNews)
28.01.14	Amgen Profit Climbs 30% (RTTNews)
28.01.14	Amgen Q4 Results Top Estimates (RTTNews)
28.01.14	Earnings Watch For January 28 (AMGN, T, EA, YHOO, DD, F) (RTTNews)
23.01.14	Amgen Reports Positive Results From Late-stage GAUSS-2 Trial Of Evolocumab (RTTNews)
10.01.14	Amgen Names Michael Kelly Interim CFO After Jonathan Peacock Resigns (RTTNews)
10.01.14	Amgen Announces Resignation Of Jonathan Peacock As CFO (RTTNews)
19.12.13	Amgen Says Phase 3 DESCARTES Trial Meets Primary Endpoint - Quick Facts (RTTNews)
17.12.13	Amgen Reports Positive Top-Line Results From Phase3 MENDEL-2 Trial Of Evolocumab (RTTNews)
25.11.13	AMGN, GSK Get FDA Nod, CLDX Walks The Talk, OREX Awaits Light, CELG On A High (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün
22.11.24		Gewinne in Frankfurt: SDAX zum Handelsende freundlich
22.11.24		EVOTEC-Aktie verliert zweistellig: US-Unternehmen Halozyme zieht Angebot für EVOTEC zurück
22.11.24		Optimismus in Frankfurt: SDAX steigt am Nachmittag
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Börse Frankfurt in Grün: TecDAX am Freitagnachmittag mit grünem Vorzeichen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün

22.11.24

Gewinne in Frankfurt: SDAX zum Handelsende freundlich

22.11.24

EVOTEC-Aktie verliert zweistellig: US-Unternehmen Halozyme zieht Angebot für EVOTEC zurück

22.11.24

Optimismus in Frankfurt: SDAX steigt am Nachmittag

22.11.24

Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag

22.11.24

Börse Frankfurt in Grün: TecDAX am Freitagnachmittag mit grünem Vorzeichen